Close
Nordic 9Nordic 9

Argobio (investor - Others)

Germany
See something wrong or missing? Let us know
Offices:Munich
Average round investment:16.54M USD
Average number per year:3.0
Distribution: 2025 (3)
Portfolio companies: France Enodia TherapeuticsNetherlands Laigo BioFrance Elkedonia
Mostly invests in: France France (2) Health services (3)

3 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Argobio

Name Criteria
Spain Invivo Capital
83%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Biotech, Manufacturing, Pharma
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 3.0
  • Active last 12 months: Yes
France Armor Group
83%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Manufacturing, Pharma
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 3.0
  • Active last 12 months: Yes
Belgium Sambrinvest
83%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Biotech, Manufacturing, Pharma
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 2.9
  • Active last 12 months: Yes
France Citizen Capital
83%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 2.7
  • Active last 12 months: Yes
Switzerland VI Partners AG
83%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Biotech, Manufacturing, Pharma
  • Similar business models: B2B
  • Common investees countries: France, Netherlands
  • Average number of deals per year: 3.3
  • Active last 12 months: Yes
France Resonance VC
83%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 3.3
  • Active last 12 months: Yes
Germany MIG Verwaltungs AG
83%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: France, Netherlands
  • Average number of deals per year: 3.4
  • Active last 12 months: Yes
Luxembourg i&i Biotech Fund
83%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Biotech, Manufacturing, Pharma
  • Similar business models: B2B
  • Common investees countries: Netherlands
  • Average number of deals per year: 2.5
  • Active last 12 months: Yes
United Kingdom Saras Capital
83%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Biotech, Manufacturing, Pharma
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 2.5
  • Active last 12 months: Yes
United States Day One Ventures
83%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 2.4
  • Active last 12 months: Yes
Top